Trending News

Changes to Civil Rights Enforcement: New Executive Order Eliminates Disparate-Impact Liability in Federal Regulations

How Are Family Offices Building Smarter Wealth? Structural Alpha (11 Examples)

DOJ Rule Restricting Sensitive Data Transfers Takes Effect

The Trump Administration’s Diversity, Equity, and Inclusion (DEI) Executive Orders: A Brief Primer

Trump Administration Announces "Reciprocal" Tariffs

What Every Multinational Company Should Know About … The Global and Reciprocal Tariffs Announcement

Blockading the Ports: U.S. Imposes 10% Global Tariff; Higher Reciprocal Tariff Rates by Country

Fifth Circuit Court of Appeals Negates Ruling on Federal Contractor Minimum Wage

New Executive Order Rescinds the $17.75 Per Hour Federal Contractor Minimum Wage

Medicare Telehealth Gets Another Temporary Lifeline – Will Congress Make it Permanent?

GlobeNewswire Biotech

Website

www.globenewswire.com

Featured Biotech Press Releases From GlobeNewswire

Latest DB-OTO Results Demonstrate Clinically Meaningful Hearing Improvements in Nearly All Children with Profound Genetic Hearing Loss in CHORD Trial
Posted On Monday, February 24, 2025
AEON Biopharma, Inc. Announces Reverse Stock Split
Posted On Monday, February 24, 2025
Harvard Bioscience Schedules Fourth Quarter 2024 Earnings Conference Call for March 12, 2025 at 8:00 AM ET
Posted On Monday, February 24, 2025
United States FDA Approves NM8074 (Ruxoprubart) IND for Treating Dermatomyositis (DM): A Chronic Inflammatory Disorder of the Skin
Posted On Monday, February 24, 2025
OrganOx Completes $142 Million Equity Financing Led by HealthQuest Capital
Posted On Monday, February 24, 2025
Bright Green Corporation Announces the completion of its restructuring plan, withdraws from the Cannabis business and sets course on the production of all DEA Scheduled Controlled Substances
Posted On Monday, February 24, 2025
Coherus Management to Participate at the 45th Annual TD Cowen Health Care Conference
Posted On Monday, February 24, 2025
Editas Medicine to Announce Fourth Quarter/Full Year 2024 Financial Results and to Participate in Investor Conferences in March
Posted On Monday, February 24, 2025
Oragenics, Inc. Chief Medical Officer, Dr. James Kelly, Joins the Medical Board of The Leigh Steinberg Foundation for Concussion, Traumatic Brain Injury, and Brain Health
Posted On Monday, February 24, 2025
Myriad Genetics Partners with PATHOMIQ to add Artificial Intelligence Technology Platform to its Oncology Portfolio
Posted On Monday, February 24, 2025
Crinetics Pharmaceuticals Appoints Tobin Schilke as Chief Financial Officer
Posted On Monday, February 24, 2025
Inozyme Pharma to Present at the TD Cowen 45th Annual Health Care Conference
Posted On Monday, February 24, 2025
CytoDyn Announces Promising Survival Observations in mTNBC Patients Treated with Leronlimab
Posted On Monday, February 24, 2025
Biodexa Announces Allowance of U.S. Patent Covering Oral Rapamycin Nanoparticle Preparations (“eRapa”) and Use
Posted On Monday, February 24, 2025
FOXO TECHNOLOGIES, INC. ANNOUNCES EXECUTION OF A NON-BINDING ACQUISITION AGREEMENT FOR TWO ASSISTED-LIVING FACILITIES IN FLORIDA FOR A TOTAL CONSIDERATION OF $60 MILLION
Posted On Monday, February 24, 2025
Sionna Therapeutics to Present at the 45th Annual TD Cowen Health Care Conference
Posted On Monday, February 24, 2025
Phathom Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Business Update on Thursday, March 6, 2025
Posted On Monday, February 24, 2025
PDS Biotech Announces Circulating Tumor DNA Results for Versamune® HPV in IMMUNOCERV Trial Published in Clinical Cancer Research
Posted On Monday, February 24, 2025
aTyr Pharma to Present at the Leerink Partners Global Healthcare Conference
Posted On Monday, February 24, 2025
Calidi Biotherapeutics Announces Commencement of Recruitment for Multiple Dose CLD-101 Trial in Patients with Newly Diagnosed High Grade Glioma at Northwestern University Hospital
Posted On Monday, February 24, 2025
Cannara Announces Extension of BMO Credit Facility and Convertible Debenture to Enhance Financial Flexibility and Support Execution of its Long-Term Strategy
Posted On Monday, February 24, 2025
Plus Therapeutics Announces Leadership Appointments for its CNSide Diagnostics Subsidiary
Posted On Monday, February 24, 2025
Cellectis Presents ‘Smart CAR T’ Strategy to Enhance Efficacy Against Solid Tumors at AACR-IO 2025
Posted On Monday, February 24, 2025
UPDATE -- BioAstra Unveils "Twin Astra": Pioneering Deep-Space Medical Research Program Set to Transform Space Exploration and Earth-Based Medicine
Posted On Sunday, February 23, 2025
IO Biotech Announces New Preclinical Data for Additional Pipeline Candidate Presented at the AACR-IO Conference
Posted On Sunday, February 23, 2025

Print